These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 28688816

  • 1. Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis.
    Lee HJ, Kim JW, Hur YH, Shin SS, Heo SH, Cho SB, Kang YJ, Lim HS, Seon HJ, Jeong YY.
    J Vasc Interv Radiol; 2017 Sep; 28(9):1240-1247.e3. PubMed ID: 28688816
    [Abstract] [Full Text] [Related]

  • 2. Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
    Lee HJ, Kim JW, Hur YH, Cho SB, Lee BC, Lee BK, Hwang EC, Cho YS, Seon HJ.
    J Vasc Interv Radiol; 2019 Mar; 30(3):284-292.e1. PubMed ID: 30819467
    [Abstract] [Full Text] [Related]

  • 3. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, Yamamoto H.
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Ardito F, De Gaetano AM, Pompili M, HepatoCATT Study Group.
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [Abstract] [Full Text] [Related]

  • 6. Chemolipiodolization with or without embolization in transcatheter arterial chemoembolization combined with radiofrequency ablation for hepatocellular carcinoma-propensity score matching analysis.
    Shi F, Zhang L, Li S, Lin CJ, Shen LJ, Li CF, Jie M, Li ZW, Wu PH.
    Oncotarget; 2016 May 24; 7(21):31311-21. PubMed ID: 27121318
    [Abstract] [Full Text] [Related]

  • 7. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.
    Kang TW, Kim JM, Rhim H, Lee MW, Kim YS, Lim HK, Choi D, Song KD, Kwon CH, Joh JW, Paik SW, Paik YH, Ahn JH.
    Radiology; 2015 Jun 24; 275(3):908-19. PubMed ID: 25688888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D, Cho SK, Shin SW, Rhim H, Koh KC, Paik SW.
    Cardiovasc Intervent Radiol; 2016 Jul 24; 39(7):1015-22. PubMed ID: 26975761
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
    Gui CH, Baey S, D'cruz RT, Shelat VG.
    Eur J Surg Oncol; 2020 May 24; 46(5):763-771. PubMed ID: 31937433
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW, Chen YS, Lo GH, Hsu YC, Hsu CC, Wu TC, Yeh JH, Hsiao P, Hsieh PM, Lin HY, Shu CW, Hung CM.
    BMC Gastroenterol; 2020 Apr 10; 20(1):99. PubMed ID: 32272898
    [Abstract] [Full Text] [Related]

  • 15. Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 m or Larger.
    Ke S, Gao J, Kong J, Ding XM, Niu HG, Xin ZH, Ning CM, Guo SG, Li XL, Zhang L, Dong YH, Sun WB.
    Medicine (Baltimore); 2016 Apr 10; 95(16):e3393. PubMed ID: 27100425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C, Liao Y, Qiu J, Yuan Y, Zhang Y, Li K, Zou R, Wang Y, Zuo D, He W, Zheng Y, Li B, Yuan Y.
    J Cancer Res Clin Oncol; 2020 Oct 10; 146(10):2669-2680. PubMed ID: 32449005
    [Abstract] [Full Text] [Related]

  • 18. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
    Guo Y, Zhang Y, Huang J, Chen X, Huang W, Shan H, Zhu K.
    J Vasc Interv Radiol; 2016 Apr 10; 27(4):487-95. PubMed ID: 26922006
    [Abstract] [Full Text] [Related]

  • 19. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study.
    Song KD, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, Paik YH, Gwak GY, Kim JM, Kwon CH, Joh JW.
    Radiology; 2015 May 10; 275(2):599-608. PubMed ID: 25559235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.